Novabay Pharmaceuticals (NBY) Stock Price, Quote & News

Company Profile

NovaBay Pharmaceuticals, Inc. manufactures and sells wound care products. The company offers hypochlorous acid for use in the cleansing and irrigation of post-surgical wounds, minor burns, and superficial abrasions. It sells its products to its distribution partners in China. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryvil...

Industry: Biotechnology

Sector: Healthcare

Phone: 510 899 8800

Fax: 510 474 1577

Website: novabay.com

Address:

2000 Powell Street, Suite 1150, eleventh floor, Emeryville, United States

Fra76 Mar. 13 at 1:15 PM

$NBY No bueno

0 · Reply

Bhaddar1 Mar. 13 at 9:59 AM

$NBY $MDCX $EONR $WTI $JTAI

0 · Reply

Bullsarmy Mar. 12 at 5:19 PM

$NBY Finally moving we will see 3+ here soon

0 · Reply

interloper Mar. 10 at 5:18 PM

$NBY I just found one share of NBY in my account. Did NBY buy out another company.

1 · Reply

PTI127 Mar. 9 at 7:24 PM

$NBY wtf happening here

0 · Reply

LongLife1 Mar. 9 at 6:38 PM

$NBY what is ht float size here

0 · Reply

Bigdubs Mar. 9 at 4:08 PM

$NBY if this hits under .85 it’s a buy. I’ve only shorted since selling all at 30+. Been a goldmine.

0 · Reply

BigBoyTroy Mar. 9 at 7:50 AM

$BTBD $PRSO $NBY $AGIG

0 · Reply

PTI127 Mar. 6 at 1:10 PM

$NBY we need to go above $3.5 soonest

1 · Reply

Bhaddar1 Mar. 5 at 11:36 PM

$ANY $EONR $NBY $UAVS $USEG 👀

0 · Reply

NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards

Sep 18, 2025, 4:30 PM EDT - 6 months ago

NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting

Aug 26, 2025, 4:05 PM EDT - 7 months ago

NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share

Aug 19, 2025, 5:25 PM EDT - 7 months ago

NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

Mar 7, 2025, 6:50 AM EST - 1 year ago

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders

Jan 23, 2025, 8:00 AM EST - 1 year ago

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal

Dec 19, 2024, 6:50 AM EST - 1 year ago

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

Dec 9, 2024, 6:50 AM EST - 1 year ago

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting

Nov 22, 2024, 4:05 PM EST - 1 year ago

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024

Nov 15, 2024, 8:00 AM EST - 1 year ago

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand

Nov 7, 2024, 4:05 PM EST - 1 year ago

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 6, 2024, 4:05 PM EST - 1 year ago

NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price

Oct 29, 2024, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC

Sep 20, 2024, 8:30 AM EDT - 1 year ago

Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals

Sep 20, 2024, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets

Aug 13, 2024, 11:29 PM EDT - 1 year ago

NovaBay Pharmaceuticals, Inc. (NBY) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 4:05 PM EDT - 1 year ago

NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results

Aug 1, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024

Jul 30, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales

Jul 29, 2024, 4:05 PM EDT - 1 year ago

NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option

Jul 26, 2024, 8:30 AM EDT - 1 year ago

NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering

Jul 16, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day

Jul 11, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million

Jul 1, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

Jun 28, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions

Jun 7, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American

May 29, 2024, 5:22 PM EDT - 1 year ago

NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates

May 13, 2024, 8:30 AM EDT - 1 year ago

NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms

May 11, 2024, 1:59 PM EDT - 2 years ago

NovaBay Pharmaceuticals, Inc. (NBY) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:05 PM EDT - 2 years ago

NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results

May 7, 2024, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon

May 3, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024

Apr 22, 2024, 6:57 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales

Apr 19, 2024, 6:00 PM EDT - 2 years ago

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity

Apr 17, 2024, 6:59 AM EDT - 2 years ago

NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses

Mar 26, 2024, 6:43 PM EDT - 2 years ago

NovaBay Pharmaceuticals, Inc. (NBY) Q4 2023 Earnings Call Transcript

Mar 26, 2024, 4:05 PM EDT - 2 years ago

NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results

Mar 25, 2024, 6:38 PM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024

Mar 14, 2024, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023

Jan 30, 2024, 9:00 AM EST - 2 years ago

NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales

Jan 9, 2024, 9:15 AM EST - 2 years ago

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

SNOA

Dec 6, 2023, 6:50 AM EST - 2 years ago

NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes

Nov 9, 2023, 11:43 PM EST - 2 years ago

NovaBay Pharmaceuticals, Inc. (NBY) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 4:05 PM EST - 2 years ago

NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results

Nov 2, 2023, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023

Oct 11, 2023, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs

Oct 2, 2023, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference

Sep 14, 2023, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft

Sep 11, 2023, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft

Fra76 Mar. 13 at 1:15 PM

$NBY No bueno

0 · Reply

Bhaddar1 Mar. 13 at 9:59 AM

$NBY $MDCX $EONR $WTI $JTAI

0 · Reply

Bullsarmy Mar. 12 at 5:19 PM

$NBY Finally moving we will see 3+ here soon

0 · Reply

interloper Mar. 10 at 5:18 PM

$NBY I just found one share of NBY in my account. Did NBY buy out another company.

1 · Reply

PTI127 Mar. 9 at 7:24 PM

$NBY wtf happening here

0 · Reply

LongLife1 Mar. 9 at 6:38 PM

$NBY what is ht float size here

0 · Reply

Bigdubs Mar. 9 at 4:08 PM

$NBY if this hits under .85 it’s a buy. I’ve only shorted since selling all at 30+. Been a goldmine.

0 · Reply

BigBoyTroy Mar. 9 at 7:50 AM

$BTBD $PRSO $NBY $AGIG

0 · Reply

PTI127 Mar. 6 at 1:10 PM

$NBY we need to go above $3.5 soonest

1 · Reply

Bhaddar1 Mar. 5 at 11:36 PM

$ANY $EONR $NBY $UAVS $USEG 👀

0 · Reply

Bhaddar1 Mar. 5 at 9:51 AM

$NBY she doesn’t like it here any more 👀

0 · Reply

giglio75 Mar. 4 at 8:43 PM

$NBY 👀

0 · Reply

Ira27 Mar. 4 at 5:55 PM

$NBY for my followers. Lets 👀

0 · Reply

Bhaddar1 Mar. 4 at 3:30 PM

$UAVS $EONR $MDCX $TPET $USEG let’s see boy $ANY $NBY BIG BULLISH HERE

0 · Reply

PTI127 Mar. 3 at 5:02 PM

$NBY let’s go watch time is over

0 · Reply

LoganzzRunn Mar. 3 at 3:00 PM

$KALA Lazar has Lasared everyones money into oblivion both here and $NBY and his others soon. Stay far far away from anything he touches. He has turned into the Dilution king. Vaporizing everyones money into dust with his bailout deals. Funny because I remember him from his days as a promoter in the OTC and he hated these guys that would dilute his stocks to hell. Now he has turned into exactly the thing he despised. Robbing everyone blind. The only good thing is he will never be able to do it again. No one will buy his crap shares anymore. Shame...he could have been one of the good guys too.

0 · Reply

Bhaddar1 Mar. 3 at 1:57 PM

$NBY watching 👀 you

0 · Reply

PTI127 Feb. 27 at 10:36 PM

$NBY I love the number here 1.43

1 · Reply

LongLife1 Feb. 27 at 9:55 PM

$NBY how tether is associated with this garbage

1 · Reply

PTI127 Feb. 27 at 8:54 PM

$NBY how far u can drop 📉 from

0 · Reply

patatechaude Feb. 26 at 9:39 PM

$NBY This is the answer.

0 · Reply

eastman71 Feb. 26 at 9:35 PM

$NBY But three days ago you were saying someone would buy the floating exchange rate and send it back up to $100!!... Have you changed your mind?... That's your right, but I prefer to trust in a rebound that benefits people.

1 · Reply

Market Cap	77.92M
Revenue (ttm)	9.78M
Net Income (ttm)	-7.22M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-73.82%
Debt to Equity Ratio	0.00

Volume	877,886
Avg Vol	2,504,516
Day's Range	N/A - N/A
Shares Out	129.61M
Stochastic %K	32%
Beta	0.14
Analysts	Strong Buy
Price Target	$0.85